Penumbra Inc
PEN · XNYSCIK 1321732fmd_09AFT0BN0B2ARQW7K53YSDC7R7Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2013 to Sep 30, 2026, 52 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 263 | 334 | 445 | 547 | 560 | 748 | 847 | 1,059 | 1,195 | 1,404 |
| Cost of revenue | 92 | 117 | 152 | 175 | 222 | 272 | 312 | 376 | 440 | 461 |
| Gross profit | 171 | 217 | 293 | 372 | 338 | 475 | 535 | 683 | 755 | 942 |
| Research and development | 24 | 32 | 36 | 52 | 90 | 105 | 79 | 84 | 95 | 90 |
| Selling, general and administrative | 148 | 184 | 226 | 273 | 287 | 378 | 450 | 506 | 574 | 663 |
| Total operating expenses | 172 | 216 | 293 | 324 | 377 | 483 | 529 | 609 | 746 | 753 |
| Operating income | (1) | 1 | (1) | 48 | (39) | (8) | 6 | 74 | 9 | 189 |
| Interest expense | – | – | – | – | – | 2 | 2 | 2 | 1 | 1 |
| Interest and investment income | – | – | – | – | – | 3 | 2 | 7 | 14 | 16 |
| Other non-operating income (expense) | (2) | (1) | (1) | (0) | (0) | (3) | (2) | 6 | 12 | 16 |
| Income before taxes | (1) | 2 | 2 | 50 | (38) | (11) | 4 | 80 | 21 | 205 |
| Income tax expense | (16) | (4) | (4) | 3 | (19) | (13) | 6 | (11) | 7 | 27 |
| Net income from continuing operations | 15 | 6 | 6 | 47 | (19) | 3 | (2) | 91 | 14 | 178 |
| Net income | 15 | 5 | 7 | 48 | (16) | 5 | (2) | 91 | 14 | 178 |
| Net income to common shareholders | 15 | 5 | – | – | – | – | – | – | – | – |